Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19

2021480 citationsJournal Articlebronze Open Access

Authors

ClinicalTrials.gov Identifier: NCT04401293.

Good health and well-being

Published in: JAMA Internal Medicine

Volume 181, Issue 12, pp. 1612-1612

Field-Weighted Citation Impact: 81.41